Northwest Biotherapeutics, Inc. (BST:NBYB)
Germany
· Delayed Price · Currency is EUR 0.184
-0.001 (-0.54%)
At close: Dec 5, 2025
Northwest Biotherapeutics Revenue
Northwest Biotherapeutics had revenue of $200.00K USD in the quarter ending September 30, 2025, a decrease of -43.98%. This brings the company's revenue in the last twelve months to $937.00K, down -41.29% year-over-year. In the year 2024, Northwest Biotherapeutics had annual revenue of $1.38M, down -28.47%.
Revenue (ttm)
$937.00K
Revenue Growth
-41.29%
P/S Ratio
391.51
Revenue / Employee
$37.48K
Employees
25
Market Cap
312.66M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.38M | -550.00K | -28.47% |
| Dec 31, 2023 | 1.93M | 249.00K | 14.80% |
| Dec 31, 2022 | 1.68M | 678.00K | 67.46% |
| Dec 31, 2021 | 1.01M | -286.00K | -22.15% |
| Dec 31, 2020 | 1.29M | -1.12M | -46.43% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Rheinmetall AG | 11.00B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Deutsche Bank Aktiengesellschaft | 29.86B |